Press "Enter" to skip to content

Efficacy of novel T-cell bispecific engaging antibody, CD20-TCB (RG6026), for R/R NHL – Lymphoma Hub

admin 0

Efficacy of novel T-cell bispecific engaging antibody, CD20-TCB (RG6026), for R/R NHL  Lymphoma Hub

During ICML 2019 in Lugano, Switzerland, the Lymphoma Hub were pleased to speak to Michael Dickinson from Peter MacCallum Cancer Center, Melbourne, …

“lymphoma cancer” – Google News

(Visited 6 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *